Search - tctmd.com

Displaying 301 - 320 of 665

Sort: Relevancy | Date

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2017

Caitlin E. Cox

August 31, 2017

News Conference News ESC 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Michael O'Riordan

August 31, 2017

Presentation iASSESS 2017

Complications of Structural Heart Disease Intervention - Part 2

Presenter: Mauricio G. Cohen

August 30, 2017

Presentation iASSESS 2017

Femoral Access and Related Complications

Presenter: Arnold Seto

August 30, 2017

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

Presentation iASSESS 2017

Complications of Structural Heart Disease Intervention - Part 1

Presenter: George Hanzel

August 30, 2017

Podcast Heart Sounds

Guidelines for the Management of Valvular Heart Disease

Presenter: Helmut Baumgartner

August 29, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Daily News

After Failed Mitral Valve Surgery, Transcatheter Valve-in-Valve or Valve-in-Ring Shows Promise in High-Risk Patients

Yael L. Maxwell

August 24, 2017

News Daily News

TAVR in the US: Regional Variations in Numbers, Outcomes

Michael O'Riordan

August 22, 2017

Presentation

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

August 22, 2017

Podcast

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

August 10, 2017

Presentation

Optimized Screening of CAD With Invasive Coronary Angiography and Ad Hoc PCI During TAVR

August 10, 2017

News Daily News

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Leah Lawrence

August 10, 2017

News Daily News

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Ashley Lyles

August 08, 2017

News Daily News

FDA Deems ‘Field Action’ for Faulty IABPs a Class I Recall

Shelley Wood

August 07, 2017

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

Podcast TCTMD Talking Points

Episode 26: PARTNER 1 5-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After TAVR in High-Risk Aortic Stenosis

August 02, 2017

Advertisement

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

TCTMD’s Top 10 Most Popular Stories for August 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Complications of Structural Heart Disease Intervention - Part 2

Femoral Access and Related Complications

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

Complications of Structural Heart Disease Intervention - Part 1

Top Stories in Cardiology, August 2017

Guidelines for the Management of Valvular Heart Disease

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

After Failed Mitral Valve Surgery, Transcatheter Valve-in-Valve or Valve-in-Ring Shows Promise in High-Risk Patients

TAVR in the US: Regional Variations in Numbers, Outcomes

Regional Variation in Utilization, In-Hospital Mortality, and Resource Use of TAVR in US

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

Optimized Screening of CAD With Invasive Coronary Angiography and Ad Hoc PCI During TAVR

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

FDA Deems ‘Field Action’ for Faulty IABPs a Class I Recall

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Episode 26: PARTNER 1 5-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After TAVR in High-Risk Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content